We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.5B
AUM Growth
-$470M
(-0.57%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
751
New
67
Increased
353
Reduced
251
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$531M |
| 2 |
Microchip Technology
MCHP
|
+$311M |
| 3 |
Check Point Software Technologies
CHKP
|
+$243M |
| 4 |
Sanofi
SNY
|
+$224M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$364M |
| 2 |
Vertiv
VRT
|
+$292M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$274M |
| 4 |
HF Sinclair
DINO
|
+$253M |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.6% |
| 2 | Healthcare | 16.65% |
| 3 | Technology | 14.96% |
| 4 | Industrials | 14.22% |
| 5 | Energy | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Haemonetics
HAE
$3.75B
| $19.1M | 0.02% |
303,525
+2,937
| +1% | +$160K |
|
|
SCS
327
DELISTED
Steelcase
SCS
| $18.1M | 0.02% |
1,528,951
+3,178
| +0.2% | +$38.4K |
|
328
Wabash National
WNC
$541M
| $17.9M | 0.02% |
1,232,054
+31,475
| +3% | +$556K |
|
|
COOP
329
DELISTED
Mr. Cooper
COOP
| $17.6M | 0.02% |
392,092
-476,476
| -55% | -$21.7M |
|
330
Nelnet
NNI
$4.92B
| $17.4M | 0.02% |
205,059
+7,164
| +4% | +$617K |
|
331
Altria Group
MO
$125B
| $17.3M | 0.02% |
331,925
-45,618
| -12% | -$2.32M |
|
332
Columbia Banking Systems
COLB
$8.84B
| $16.9M | 0.02% |
526,997
+1,581
| +0.3% | +$55.4K |
|
333
Par Pacific Holdings
PARR
$3.97B
| $16.8M | 0.02% |
+1,281,843
| New | +$18.3M |
|
334
First American
FAF
$8.08B
| $16.4M | 0.02% |
255,216
+143
| +0.1% | +$10.2K |
|
335
Lithia Motors
LAD
$8.17B
| $16M | 0.02% |
53,183
+21,758
| +69% | +$6.79M |
|
336
AES
AES
$10.6B
| $15.9M | 0.02% |
618,540
-30,757
| -5% | -$695K |
|
337
Toll Brothers
TOL
$14.5B
| $15.8M | 0.02% |
337,252
+935
| +0.3% | +$52.4K |
|
|
NESR
338
National Energy Services Reunited Corp
NESR
$2.58B
| $15.8M | 0.02% |
1,878,900
+99,074
| +6% | +$943K |
|
339
Ameris Bancorp
ABCB
$5.9B
| $15.7M | 0.02% |
360,942
+2,495
| +0.7% | +$123K |
|
340
Turning Point Brands
TPB
$1.56B
| $15.6M | 0.02% |
461,254
-61,545
| -12% | -$2.09M |
|
341
The Mosaic Company
MOS
$7.34B
| $15.2M | 0.02% |
228,868
-3,441,218
| -94% | -$172M |
|
342
Werner Enterprises
WERN
$2.3B
| $15.2M | 0.02% |
373,002
-243
| -0.1% | -$10.7K |
|
343
Ecovyst
ECVT
$1.35B
| $14.6M | 0.02% |
1,266,927
-42,577
| -3% | -$447K |
|
344
Microsoft
MSFT
$2.92T
| $14.3M | 0.02% |
46,351
+2,193
| +5% | +$660K |
|
345
ScottsMiracle-Gro
SMG
$4.25B
| $14.1M | 0.02% |
114,579
+84,853
| +285% | +$11.9M |
|
346
Minerals Technologies
MTX
$2.33B
| $13.5M | 0.02% |
205,277
-280
| -0.1% | -$19.4K |
|
347
Terex
TEX
$7.84B
| $13.3M | 0.02% |
375,954
+960
| +0.3% | +$39.7K |
|
348
Webster Financial
WBS
$12.5B
| $13.1M | 0.02% |
234,268
-6,328
| -3% | -$376K |
|
|
ACRE
349
Ares Commercial Real Estate
ACRE
$256M
| $12.9M | 0.02% |
835,221
+2,656
| +0.3% | +$39.1K |
|
|
AMED
350
DELISTED
Amedisys
AMED
| $12.7M | 0.02% |
73,945
+67,194
| +995% | +$10M |
|
Similar funds
Boston Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Boston Partners held 751 positions worth $82.5B, down 0.57% from $83B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q1 2022 filing shows 67 new, 353 increased, 251 reduced and 53 closed positions. Its largest new stake was Microchip Technology: 4,127,908 shares worth $310M. The largest sale was Citigroup, an estimated $364M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2022 buy was Microchip Technology: 4,127,908 shares worth $310M.
- Boston Partners added most to Procter & Gamble in Q1 2022, an estimated $531M increase.
- Boston Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $364M.
- Boston Partners fully exited Vertiv in Q1 2022, selling an estimated $292M.
- Boston Partners's ten largest holdings make up 14% of its $82.5B portfolio in Q1 2022.
- Boston Partners opened 67 new positions and closed 53 in Q1 2022.
- Boston Partners's portfolio value fell 0.57% quarter-over-quarter to $82.5B.
Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.